Bioxyne swings to first significant profit on surging domestic sales by Adam Sheldon August 29, 2025August 29, 2025 Bioxyne posted a full-year profit of $4.9 million for the 12 months to June 30, 2025, […]
News in brief: Losses widen for Avecho and Elixinol; InhaleRx secures HREC approval; Zelira cuts deficit; Argent shifts from ‘non-core’ activities by Adam Sheldon August 29, 2025February 21, 2026
Cannabis Council Australia to run free webinars on TGA review by Adam Sheldon August 29, 2025February 21, 2026
Montu calls for single prescriber framework in TGA submission by Adam Sheldon August 28, 2025August 28, 2025
News in brief: Wragg joins ANTG; Bioxyne launches legal claim; Epsilon appoints Kaplon by Martin Lane August 28, 2025February 21, 2026
Australia’s GMP mirage: why ‘EU-GMP equivalent’ fails the global cannabis test by Michael Sassano August 26, 2025August 26, 2025
LGP avoids second strike as shareholders back pay report by Adam Sheldon August 25, 2025August 25, 2025
Vitura posts $3.1m profit, third dividend amid price pressure by Adam Sheldon August 25, 2025August 26, 2025
Althea creditors to recover four cents in the dollar under DOCA by Adam Sheldon August 20, 2025August 20, 2025
